Segui
Tilo Grosser
Tilo Grosser
Bielefeld University
Email verificata su itmat.upenn.edu - Home page
Titolo
Citata da
Citata da
Anno
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
T Grosser, S Fries, GA FitzGerald
The Journal of clinical investigation 116 (1), 4-15, 2006
13382006
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis
TE North, W Goessling, CR Walkley, C Lengerke, KR Kopani, AM Lord, ...
Nature 447 (7147), 1007-1011, 2007
12972007
Role of prostacyclin in the cardiovascular response to thromboxane A2
Y Cheng, SC Austin, B Rocca, BH Koller, TM Coffman, T Grosser, ...
Science 296 (5567), 539-541, 2002
10872002
Understanding multicellular function and disease with human tissue-specific networks
CS Greene, A Krishnan, AK Wong, E Ricciotti, RA Zelaya, ...
Nature genetics 47 (6), 569-576, 2015
9112015
Prostanoids in health and disease
EM Smyth, T Grosser, M Wang, Y Yu, GA FitzGerald
Journal of lipid research 50, S423-S428, 2009
6582009
The clinical pharmacology of nonsteroidal antiinflammatory drugs and coxibs.
T Grosser
Applied pharmacokinetics & pharmacodynamics: Principles of therapeutic drug …, 2006
339*2006
Timing of expression of the core clock gene Bmal1 influences its effects on aging and survival.
FGGA Yang G, Chen L, Grant GR, Paschos G, Song WL, Musiek ES, Lee V ...
Sci Transl Med 8, 324, 2016
3292016
Antiinflammatory, antipyretic and analgesic agents
T Grosser, EM Smyth, GA FitzGerald
Goodman and Gilman’s the Pharmacological Basis of Therapeutics (12th Edition …, 2011
317*2011
Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin
T Grosser, S Fries, JA Lawson, SC Kapoor, GR Grant, GA FitzGerald
Circulation 127 (3), 377-385, 2013
3052013
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs
KN Theken, CR Lee, L Gong, KE Caudle, CM Formea, A Gaedigk, ...
Clinical Pharmacology & Therapeutics 108 (2), 191-200, 2020
2982020
Emotion recollected in tranquility: lessons learned from the COX-2 saga
T Grosser, Y Yu, GA FitzGerald
Annual review of medicine 61 (1), 17-33, 2010
2612010
Developmental expression of functional cyclooxygenases in zebrafish
T Grosser, S Yusuff, E Cheskis, MA Pack, GA FitzGerald
Proceedings of the National Academy of Sciences 99 (12), 8418-8423, 2002
2582002
Celecoxib pathways: pharmacokinetics and pharmacodynamics
L Gong, CF Thorn, MM Bertagnolli, T Grosser, RB Altman, TE Klein
Pharmacogenetics and genomics 22 (4), 310-318, 2012
2372012
The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs
T Grosser, E Ricciotti, GA FitzGerald
Trends in pharmacological sciences 38 (8), 733-748, 2017
1962017
Deciphering the human platelet sheddome
KP Fong, C Barry, AN Tran, EA Traxler, KM Wannemacher, HY Tang, ...
Blood, The Journal of the American Society of Hematology 117 (1), e15-e26, 2011
1942011
Bioinformatic analysis of circadian gene oscillation in mouse aorta
RD Rudic, P McNamara, D Reilly, T Grosser, AM Curtis, TS Price, ...
Circulation 112 (17), 2716-2724, 2005
1812005
Enteric coating and aspirin nonresponsiveness in patients with type 2 diabetes mellitus
DL Bhatt, T Grosser, J Dong, D Logan, W Jeske, DJ Angiolillo, ...
Journal of the American College of Cardiology 69 (6), 603-612, 2017
1802017
Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2
S Fries, T Grosser, TS Price, JA Lawson, S Kapoor, S DeMarco, ...
Gastroenterology 130 (1), 55-64, 2006
1682006
Analysis of the zebrafish proteome during embryonic development
MB Lucitt, TS Price, A Pizarro, W Wu, AK Yocum, C Seiler, MA Pack, ...
Molecular & Cellular Proteomics 7 (5), 981-994, 2008
1642008
Prostanoids and inflammatory pain
L Chen, G Yang, T Grosser
Prostaglandins & other lipid mediators 104, 58-66, 2013
1542013
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20